|
|
|
|
|
|
|
Uscf Summerhaven Shpei Index Fund (BUY)
|
|
25.7201 0.03 (0.12%)
|
04-26 14:19
|
|
Open:
|
25.72
|
Pre. Close:
|
25.69
|
|
High:
|
25.7201
|
Low:
|
25.72
|
|
Volume:
|
800
|
Market Cap:
|
0M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
25.753 - 25.858
|
25.858 - 25.957
|
|
Low:
|
25.455 - 25.573
|
25.573 - 25.686
|
|
Close:
|
25.534 - 25.716
|
25.716 - 25.89
|
|
|
|
Technical analysis (as of: 2018-04-26 4:28:14 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 30.36 One year: 35.46
|
|
Support:
|
Support1: 25.00 Support2: 24.38
|
|
Resistance:
|
Resistance1:
25.99 Resistance2: 30.36
|
|
Pivot:
|
25.42 
|
|
Moving Averages:
|
MA(5): 25.70  MA(20): 25.21
MA(100): 25.12 MA(250):
|
|
MACD:
|
MACD(12,26):
0.23 Signal(12,26,9): 0.18
|
|
%K %D:
|
%K(14,3): 73.78 %D(3): 77.06
|
|
RSI:
|
RSI(14): 65.35
|
|
52-Week:
|
High: 27.03
Low: 2.65 Change(%): -42.2
|
|
Average Vol(K):
|
3-Month: 45
10-Days 29
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.BUY has closed below upper band by 29.0%. Bollinger Bands are 82.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to BUY's normal range. The bands have been in this narrow range for {EMPTY} bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-01-05T09:21:35-05:00
BofA/Merrill Lynch bullish on biopharma in 2018
2017-12-01T09:00:00-05:00
USCF Announces the Launch of Two New Funds that are Designed to Track the SummerHaven Private Equity Strategy Indexes (Tickers: BUY, BUYN)
2018-01-05T09:21:35-05:00
BofA/Merrill Lynch bullish on biopharma in 2018
2017-12-01T09:00:00-05:00
USCF Announces the Launch of Two New Funds that are Designed to Track the SummerHaven Private Equity Strategy Indexes (Tickers: BUY, BUYN)
2018-01-05T09:21:35-05:00
BofA/Merrill Lynch bullish on biopharma in 2018
2017-12-01T09:00:00-05:00
USCF Announces the Launch of Two New Funds that are Designed to Track the SummerHaven Private Equity Strategy Indexes (Tickers: BUY, BUYN)
2018-01-05T09:21:35-05:00
BofA/Merrill Lynch bullish on biopharma in 2018
2017-12-01T09:00:00-05:00
USCF Announces the Launch of Two New Funds that are Designed to Track the SummerHaven Private Equity Strategy Indexes (Tickers: BUY, BUYN)
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
